A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
Clinical trial NCT03492580 · COMPLETED
Trial details
- NCT number
- NCT03492580
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-02-22
- Primary completion
- 2018-04-06
- Enrollment
- 714582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.